Rubin RH - Search Results

1

The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy.

Marty FM, Rubin RH. Marty FM, et al. Among authors: rubin rh. Transpl Int. 2006 Jan;19(1):2-11. doi: 10.1111/j.1432-2277.2005.00218.x. Transpl Int. 2006. PMID: 16359371 Free article. Review.

2

Principles of antimicrobial therapy in the transplant patient.

Rubin RH, Marty FM. Rubin RH, et al. Transpl Infect Dis. 2004 Sep;6(3):97-100. doi: 10.1111/j.1399-3062.2004.00070.x. Transpl Infect Dis. 2004. PMID: 15569224 No abstract available.

3

Diagnostic efficacy and safety of computed tomography-guided transthoracic needle biopsy in patients with hematologic malignancies.

Kallenberg MH, Gill RR, Factor RE, Bryar JM, Rubin RH, Jacobson FL, Marty FM. Kallenberg MH, et al. Among authors: rubin rh. Acad Radiol. 2009 Nov;16(11):1408-15. doi: 10.1016/j.acra.2009.06.008. Epub 2009 Aug 15. Acad Radiol. 2009. PMID: 19683945

4

The persistent challenges of bacterial infections in the transplant recipient.

Marty FM, Rubin RH. Marty FM, et al. Among authors: rubin rh. Transpl Infect Dis. 2006 Sep;8(3):125-7. doi: 10.1111/j.1399-3062.2006.00168.x. Transpl Infect Dis. 2006. PMID: 16913970 No abstract available.

5

Transplant infectious disease as a subspecialty: does outlining how we train define who we are?

Marty FM, Hirsch HH, Rubin RH. Marty FM, et al. Among authors: rubin rh. Transpl Infect Dis. 2010 Jun;12(3):187-9. doi: 10.1111/j.1399-3062.2010.00518.x. Transpl Infect Dis. 2010. PMID: 20624258 No abstract available.

6

Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.

Rubin RH, Kemmerly SA, Conti D, Doran M, Murray BM, Neylan JF, Pappas C, Pitts D, Avery R, Pavlakis M, Del Busto R, DeNofrio D, Blumberg EA, Schoenfeld DA, Donohue T, Fisher SA, Fishman JA. Rubin RH, et al. Transpl Infect Dis. 2000 Sep;2(3):112-7. Transpl Infect Dis. 2000. PMID: 11429021 Clinical Trial.

7

Dosing of intravenous ganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplant recipients.

Fishman JA, Doran MT, Volpicelli SA, Cosimi AB, Flood JG, Rubin RH. Fishman JA, et al. Among authors: rubin rh. Transplantation. 2000 Feb 15;69(3):389-94. doi: 10.1097/00007890-200002150-00014. Transplantation. 2000. PMID: 10706048 Clinical Trial.

8

Prevention and treatment of cytomegalovirus disease in heart transplant patients.

Rubin RH. Rubin RH. J Heart Lung Transplant. 2000 Aug;19(8):731-5. doi: 10.1016/s1053-2498(00)00096-6. J Heart Lung Transplant. 2000. PMID: 10967265 Review.

9

Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole.

Baden LR, Katz JT, Franck L, Tsang S, Hall M, Rubin RH, Jarcho J. Baden LR, et al. Among authors: rubin rh. Transplantation. 2003 Feb 15;75(3):339-43. doi: 10.1097/01.TP.0000044864.99398.F1. Transplantation. 2003. PMID: 12589155

10

Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.

Turgeon N, Fishman JA, Basgoz N, Tolkoff-Rubin NE, Doran M, Cosimi AB, Rubin RH. Turgeon N, et al. Among authors: rubin rh. Transplantation. 1998 Dec 27;66(12):1780-6. doi: 10.1097/00007890-199812270-00036. Transplantation. 1998. PMID: 9884276

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters